— Know what they know.
Not Investment Advice

PPD NASDAQ

PPD, Inc.
1W: +0.4% 1M: +0.0% 3M: +1.3% 1Y: +33.8%
$47.28
Last traded 2021-12-07 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Revenue Segmentation

By Product / Service

By Geography

Income Trends

Revenue
$4.7B +16.1% ▲
4Y CAGR: +15.0%
Gross Profit
$1.8B +10.9% ▲
4Y CAGR: +8.6%
Operating Income
$509M +21.7% ▲
4Y CAGR: +12.8%
Net Income
$154M +221.4% ▲
4Y CAGR: -4.3%
EPS (Diluted)
$0.44 +214.3% ▲
4Y CAGR: -5.9%
EBITDA
$684M +6.6% ▲
4Y CAGR: +2.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2016FY2017FY2018FY2019FY2020
Revenue$2.7B$3.0B$3.7B$4.0B$4.7B
YoY Growth+0.0%+12.0%+24.9%+7.5%+16.1%
Cost of Revenue$1.4B$1.5B$2.3B$2.4B$2.9B
Gross Profit$1.3B$1.5B$1.5B$1.6B$1.8B
Gross Margin48.2%48.8%39.3%40.2%38.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$0$0$0$0$0
Operating Expenses$979M$1.2B$1.1B$1.2B$1.3B
Operating Income$314M$261M$402M$418M$509M
Operating Margin11.7%8.7%10.7%10.4%10.9%
Interest Expense$203M$254M$264M$312M$217M
Income Before Tax$167M$16M$147M$51M$172M
Tax Expense-$16M-$284M$40M$3M$19M
Net Income$183M$296M$104M$48M$154M
Net Margin6.8%9.9%2.8%1.2%3.3%
EPS (Diluted)$0.56$0.91$0.32$0.14$0.44
EBITDA$631M$545M$666M$636M$684M
Shares Outstanding324M326M324M339M347M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms